Newsletter n.6

The I-GENE team is pleased to welcome you to the 6th issue of the IGENE newsletter.

I am proud to say that the team realized some major
achievements during the last months. We have optimized the chemistry
of our nanoformulation, in terms of stability and ability to
spontaneously cross the membranes of human melanoma cells to edit

Moreover, the superiority of our approach lies in the ability to
switch the system on with light which increases the safety level of the
technology and acceptability for future clinical applications. Please,
stay up to date on the I-GENE project by reading this and next project